Trial Profile
A Single-Center Study Assessing The Effect Of Tenofovir Disproxil Fumarate (TDF) On Bone Density In Liver Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2020
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Basiliximab
- Indications Hepatitis
- Focus Adverse reactions
- 31 Oct 2020 Results (n=363) published in the Transplantation Proceedings
- 12 May 2017 New trial record
- 03 May 2017 Results presented at the 2017 American Transplant Congress.